The correlation was further reversely validated by the work of Zhou et al., in which knockdown of ANXA3 by shRNA impaired the invasion and migration abilities of luminal A and triple negative breast cancer cells (Zhou et al., 2017a). This evidence concerns the gene ANXA3 and triple-negative breast carcinoma.